Drew Deniger - 15 Sep 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
VP, Research and Development
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
15 Sep 2022
Net transactions value
$0
Form type
4
Filing time
19 Sep 2022, 16:30:41 UTC
Previous filing
08 Apr 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +305,000 $0.000000 305,000 15 Sep 2022 Common Stock 305,000 $2.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney